Rowald A, Amft O (2022)
Publication Type: Journal article
Publication year: 2022
Book Volume: 16
Article Number: 983072
DOI: 10.3389/fnbot.2022.983072
A growing number of complex neurostimulation strategies promise symptom relief and functional recovery for several neurological, psychiatric, and even multi-organ disorders. Although pharmacological interventions are currently the mainstay of treatment, neurostimulation offers a potentially effective and safe alternative, capable of providing rapid adjustment to short-term variation and long-term decline of physiological functions. However, rapid advances made by clinical studies have often preceded the fundamental understanding of mechanisms underlying the interactions between stimulation and the nervous system. In turn, therapy design and verification are largely driven by clinical-empirical evidence. Even with titanic efforts and budgets, it is infeasible to comprehensively explore the multi-dimensional optimization space of neurostimulation through empirical research alone, especially since anatomical structures and thus outcomes vary dramatically between patients. Instead, we believe that the future of neurostimulation strongly depends on personalizable computational tools, i.e. Digital Neuro Twins (DNTs) to efficiently identify effective and safe stimulation parameters. DNTs have the potential to accelerate scientific discovery and hypothesis-driven engineering, and aid as a critical regulatory and clinical decision support tool. We outline here how DNTs will pave the way toward effective, cost-, time-, and risk-limited electronic drugs with a broad application bandwidth.
APA:
Rowald, A., & Amft, O. (2022). A computational roadmap to electronic drugs. Frontiers in Neurorobotics, 16. https://dx.doi.org/10.3389/fnbot.2022.983072
MLA:
Rowald, Andreas, and Oliver Amft. "A computational roadmap to electronic drugs." Frontiers in Neurorobotics 16 (2022).
BibTeX: Download